Earmarked funding – call 2022.2
Disruptive innovations happen when different technology domains join forces.
In 2022 MEDVIA supported by VLAIO provides €8 million earmarked non-dilutive funding for innovations in biotechnology, medical technology, and digital technology.
The projects – combining at least two of the above domains – should develop disruptive solutions for a clearly defined unmet need in healthcare or pool their research strengths to gain knowledge that will lead to such solutions. The results need to lead to a quantifiable increase in investment and employment in Flanders.
Your project should connect with one of our four overarching themes: Value-based healthcare, personalised medicine, digital medicine, or disruptive health solutions.
Full detail of the criteria and deadlines can be found in the PDF document.
Please note that this call is now in the full proposal phase.
Full proposal templates
The full proposal deadline is on the 1st of September 2022.
Grant options.
We opened four different VLAIO grant schemes:
We help you succeed.
MEDVIA assists participants with the preparation of their proposal. Of course, all participants bear full and final responsibility for writing and preparing a proposal that meets the criteria set by VLAIO for the respective grant schemes.
Interested in our future calls?
By signing up you agree with our Privacy Policy
Better together
and
are joining forces in a brand new organization
The members of MEDVIA and flanders.bio have voted to merge their activities in the first half of 2025. With a united voice, we will champion the entire healthtech and biotech ecosystem on the regional, federal and European stage.
The merger allows MEDVIA and flanders.bio to align activities and deliver more powerful support for our collective members. We will achieve greater impact with more dynamic networking opportunities, better directed funding and increased efficiency, sharpening our focus in common areas and drafting strategic roadmaps for Flanders.